Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Gene Therapy for Oral Cancer

  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

New treatment approaches are needed to improve the effectiveness of oral cancer treatment, since surgical resection of the tumor in oral region causes various oral dysfunctions. The molecular biology of oral cancer has been progressively delineated. Concurrently, gene therapy techniques have been developed that allow targeting or replacement of dysfunctional genes in cancer cells, offering the potential to treat a wide range of cancer. Oral carcinoma is attractive target for gene therapy because of its accessibility. In this article, we review the current status of gene therapy as applied to oral carcinoma.

Keywords

References

  1. Adis International Limited. (2007). INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201. Drugs in R&D. 8(3), 176-187 https://doi.org/10.2165/00126839-200708030-00005
  2. Bettendorf, O., Piffko, J., and Bankfalvi, A. (2004). Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Onc. 40(2), 110- 119 https://doi.org/10.1016/j.oraloncology.2003.08.010
  3. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J.A., Sampson-Johannes, A., Fattaey, A., and McCormick, F. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 274(5286), 373-376 https://doi.org/10.1126/science.274.5286.373
  4. Carroll, M. W., Oerwijk, W. W., Chamberlain, R. S., et al. (1997). Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model. Vaccine. 15, 387-394 https://doi.org/10.1016/S0264-410X(96)00195-8
  5. Chen, S., Fribley, A., and Wang, C. Y. (2002). Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NFkappaB inhibitor. J. Dental. Res. 81(2), 98-102 https://doi.org/10.1177/154405910208100203
  6. Cheng, L., Ziegelhoffer P. R., and Yang, N. S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. U. S. A. 90(10), 4455-4459 https://doi.org/10.1073/pnas.90.10.4455
  7. Chung, I. (2003). Cancer gene Therapgy : History and Major Developments. J. Toxicol. Pub. Health. 19(3), 247-257
  8. Clayman, G. L., Trapnell, B. C., Mittereder, N., Liu, T. J., Eicher, S., Zhang, S., and Shillitoe, E. J. (1995). Tranduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther. 2(2), 105-111
  9. Darby, W., Christine, J., Smith, B. B., Xu, L., Kregel, K. C., Ritchie, J. M., Davis, C. S., and Oberley, L. W. (2003). Inhibition of oral cancer cell growth by adenovirusMnSOD plus BCNU treatment. Free Radical Biol. Medicine. 34(3), 316-329 https://doi.org/10.1016/S0891-5849(02)01245-5
  10. Dasgupta, S., Tripathi, P. K., Bhattacharya-Chatterjee, M., O'Malley, B., and Chatterjee, S. K. (2003). Recombinant vaccinia virus expressing IL-2 generates effective anti-tumor responses in an orthotopic murine model of head and neck carcinoma. Mol. Ther. 8(2), 238-248 https://doi.org/10.1016/S1525-0016(03)00148-5
  11. Dehari, H., Ito, Y., Nakamura, T., Kobune, M., Sasaki, K., Yonekura, N., Kohama, G., and Hamada, H. (2003). Enhanced antitumor effect of RFD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther. 10(1), 75-85 https://doi.org/10.1038/sj.cgt.7700529
  12. Ding, X., Chen, Y., Li, L., Liu, R., Huang, J., Lai, K., Wu, X., Ke, M., and Huang, W. (2003). Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene. Chinese J. Cancer. 22(11), 1152-1157
  13. Emery, D. W. (2004). Gene therapy for genetic diseases: On the horizon. Clin. and Appl. Immun. 4( 6), 411-422 https://doi.org/10.1016/j.cair.2004.05.001
  14. Fukui, T., Hayashi, Y., Kagami, H., Yamamoto, N., Fukuhara, H., Tohnai, I., Ueda, M., Mizuno, M., and Yoshida, J (2001). Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector. Oral Oncol. 37(3), 211-215 https://doi.org/10.1016/S1368-8375(00)00093-2
  15. Ganly, I., Kirn, D., Eckhardt, G., Rodriguez, G. I., Soutar, D. S., Otto, R., Robertson, A. G., Park, O; Gulley, M. L., Heise, C., Von Hoff, D. D., Kaye, S. B., and Eckhardt, S. G. (2000). A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin. Cancer Res. 6(3), 798-806
  16. Gibson, S. A., Pellenz, C., Hutchison, R. E., Davey, F. R., and Shillitoe, E. J. (2000). Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by and adenovirus vector. Clin. Cancer Res. 6(1), 213-222
  17. Harada, K. S., Kawaguchi, S., Onoue, T., Kawashima, Y., Yoshida, H., and Sato, M. (2005). High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation. Oncol. Reports. 13(2), 201-206
  18. Jiang, G., Li, J., Zeng, Z., and Xian, L. (2006). Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol. Ther. 5(4), 435-440 https://doi.org/10.4161/cbt.5.4.2542
  19. Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., Randlev, B., Gillenwater, A. M., Bruso, P., Kaye, S. B., Hong, W. K., Kirn, D. H. (2000). A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6(8), 879-885 https://doi.org/10.1038/78638
  20. Konopka, K., Fallah, B,. Monzon-Duller, J., Overlid, N., and Duzgunes, N. (2005). Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ ganciclorvir-mediated cytotoxicity. Cell. Mol. Biol. Letter. 10(3), 455-470
  21. Kudo, Y., Kitajima, S., Ogawa, I., Kitagawa, M., Miyauchi, M., and Takata, T. (2005). Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degrdation. Mol. Cancer Ther. 4(3), 471-476
  22. Majhen, D., and Ambrioviæ-Ristov, A. (2006). Adenoviral vectors- How to use them in cancer gene therapy. Virus Res. 119(2), 121-133 https://doi.org/10.1016/j.virusres.2006.02.001
  23. Masiero, M., Nardo, G., Indraccolo, S., and Favaro, E. (2007). RNA interference: Implications for cancer treatment. Mol. Aspects of Medicine. 28(1), 143-166 https://doi.org/10.1016/j.mam.2006.12.004
  24. Matsumoto, G., Sasakuri, K., Tsukinoki, K., Ohmi, Y., Lee, U., and Shindo, J. (2002). Growth of human squamous cell carcinoma xenografts in mice is inhibited by local angiostatin gene therapy. Oral Oncol. 38(6), 543-548 https://doi.org/10.1016/S1368-8375(01)00126-9
  25. Monahan, P. E., and Samulski, R. J. (2000). Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Medicine Today. 6(11), 433-440 https://doi.org/10.1016/S1357-4310(00)01810-4
  26. Morley, S., MacDonald, G., Kirn, D., Kaye, S., Brown, R., and Soutar, D. (2004). The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma. Clin. Cancer Res. 10(13), 4357-4362 https://doi.org/10.1158/1078-0432.CCR-03-0443
  27. Naldini, L., Blomer, U., and P. Gallay, P. et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science. 272, 263-267 https://doi.org/10.1126/science.272.5259.263
  28. Neves, S. S., Sarmento-Ribeiro, A. B., Simoes, S. P., and Pedroso de Lima, M. C. (2006). Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy. Biochim. Biophys. Acta. 1758(11), 1703-1712 https://doi.org/10.1016/j.bbamem.2006.08.021
  29. Nishikawa, M., Hashida, M. (2002). Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol. Pharm. Bull. 25, 275-283 https://doi.org/10.1248/bpb.25.275
  30. Novina, C. D., and Sharp, P. A. (2004). The RNAi revolution. Nature. 430(6996), 161-164 https://doi.org/10.1038/430161a
  31. O'Malley, B. W., Cope, K. A., Chen, S. H., Li, D., Schwarta, M. R., and Woo, S. L. (1996). Combination gene therapy for oral cancer in a murine model. Cancer Res. 56(8), 1737-1741
  32. O'Malley, B. W., Li, D., Buckner, A., Duan, L., Woo, S. L., and Pardoll, D. M. (1999). Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer. The Laryngoscope. 109(3), 389-395 https://doi.org/10.1097/00005537-199903000-00009
  33. Pang, S., Kang, M. K., Kung, S., Yu, D., Lee, A., Poon, B., Chen, I. S., Lindemann, B., and Park, N. H. (2001). Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr. Clin. Cancer Res. 7(11), 3567-3573
  34. Parkin, D. M., Pisani, P., and Ferlay, J. (1993). Estimates of the worldwide incidence of eighteen major cancers. Int. J. Cancer. 594-606
  35. Pettit, S. J., Seymour, K., O'Flaherty, E., and Kirby, J. A. (2000). Immune selection in neoplasia: towards a microevolutionary model of cancer development. Br. J. Cancer. 82(12), 1900-1906 https://doi.org/10.1054/bjoc.2000.1206
  36. Portsmouth, D., Hlavaty, J., and Renner, M. (2007). Suicide genes for cancer therapy. Mol. Aspects Med. 28(1), 4-41 https://doi.org/10.1016/j.mam.2006.12.001
  37. Sewell, D. A., Li, D., Duan, L., Westra, W. H., and O'Malley, B. W. (1997). Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch. Otolaryngol. 123(12), 1298-1302 https://doi.org/10.1001/archotol.1997.01900120048007
  38. Shillitoe, E. J., and Noonan, S. (2000). Strength and specificity of different gene promoters in oral cancer cells. Oral Oncol. 36(2), 214-220 https://doi.org/10.1016/S1368-8375(99)00064-0
  39. Xu, Dong., McCarty, D., Fernandes, A., Fisher, M., Samulski, R. J., and Juliano, R. L. (2005). Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. Mol. Ther. 11(4), 523-530 https://doi.org/10.1016/j.ymthe.2004.12.019
  40. Yamamoto, N., Hayashi, Y., Kagami, H., Fukui, T., Fukuhara, H., Tohnai, I., Ueda, M., Mizuno, M., and Yoshida, J. (2005). Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro. Nagoya J. of Med. Science. 67(3-4), 83-91
  41. Yanamoto, S., Iwamoto, T., Kawasaki, G., Yoshitomi, I., Baba, N., and Mizuno, A. (2005). Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells. Cancer letters. 223(1), 67-76 https://doi.org/10.1016/j.canlet.2004.10.019
  42. Yanamoto, S., Kawasaki, G., Yoshitomi, I., Iwamoto, T., Hirata, K., and Mizuno, A. (2007). Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Onc., In Press, Corrected Proof, Available online 4 January 2007
  43. Young, M., Overlid, N., Konopka, K., and Duzgunes, N. (2005). Gene therapy for oral cancer: efficient deliver of a suicide gene to murine oral cancer cells in physiological milieu. J. California Dental Assoc. 33(12), 967-971.abb